Synthesis of Copper Oxide-Based Nanoformulations of Etoricoxib and Montelukast and Their Evaluation through Analgesic, Anti-Inflammatory, Anti-Pyretic, and Acute Toxicity Activities

Copper oxide nanoparticles (CuO NPs) were synthesized through the coprecipitation method and used as nanocarriers for etoricoxib (selective COX-2 inhibitor drug) and montelukast (leukotriene product inhibitor drug) in combination therapy. The CuO NPs, free drugs, and nanoformulations were investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sulaiman, Sulaiman, Ahmad, Shabir, Naz, Syeda Sohaila, Qaisar, Sara, Muhammad, Sayyar, Alotaibi, Amal, Ullah, Riaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875186/
https://www.ncbi.nlm.nih.gov/pubmed/35209221
http://dx.doi.org/10.3390/molecules27041433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875186/
https://www.ncbi.nlm.nih.gov/pubmed/35209221
http://dx.doi.org/10.3390/molecules27041433

Ejemplares similares